from Reuters: U.S. https://ift.tt/2HooNrf
//
U.S. drug prices hit by insurer tactic against copay assistance: analysis
June 06, 2018 / / in news, Reuters: U.S. / with No comments /
NEW YORK (Reuters) - A recently adopted tactic by U.S. health plans to limit the financial assistance drugmakers provide directly to consumers for prescription medicines is taking a toll on drug prices, according to a new analysis released on Tuesday.
from Reuters: U.S. https://ift.tt/2HooNrf
//
from Reuters: U.S. https://ift.tt/2HooNrf
//
Related Posts:
U.S. returns $505 million to victims of giant payday lending scheme- Man deported six times charged with murder in California bludgeonings
- U.S. court upholds Louisiana restriction on abortion clinics
- South Carolina city hopeful as flooding remains a threat
- Broad losses, scant insurance coverage for storm-hit Puerto Rico firms: Fed report
0 comments:
Post a Comment